Appco Pharma LLC: Prazosin Hydrochloride Capsules, USP, 2mg, 100-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ, Manufactured by: Ap
Read the official notice at FDA (drug) →
The text below is copied from the official FDA (drug) record. If anything differs, the official notice is correct.
- Company / brand
- Appco Pharma LLC
- Product
- Prazosin Hydrochloride Capsules, USP, 2mg, 100-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ, Manufactured by: Appco Pharma LLC, Piscataway, NJ, NDC 70377-067-11.
- Reason / hazard
- cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impurity C (NNP) above acceptable limits.
- Classification
- Class II
- Status
- Ongoing
- Distribution / sold at
- U.S.A. Nationwide
- Recall initiated
- 2026-03-27
- Code info
- Lot:2404153UC, Exp.: 2026/MAR; 2404154UC, Exp.:2026/MAR; 2502055UC, Exp.: 2027/JAN; 2505173UC, Exp.: 2027/MAY; 2505175UC, Exp.: 2027/MAY.
- Product quantity
- 58,896 bottles- 100's count
- Voluntary mandated
- Voluntary: Firm initiated
- City
- Piscataway
- State
- NJ
- Country
- United States
- Event id
- 98658
Free daily digest + "My products" watchlist